Glaucoma as Neurodegeneration in the Brain
Jane W Chan1, Noel C Y Chan2, Alfredo A Sadun1,3
1Department of Ophthalmology, Doheny Eye Institute, Pasadena, CA, USA.
Eye and Brain
|January 27, 2021
Summary
Glaucoma and Alzheimer's disease share common neurodegenerative pathways, suggesting a link between optic nerve degeneration and brain disorders. This review explores the pathogenic overlap, particularly focusing on the Apolipoprotein E gene in primary open angle glaucoma.
Area of Science:
- Ophthalmology
- Neuroscience
- Genetics
Background:
- Glaucoma involves progressive optic nerve degeneration, leading to irreversible blindness.
- Emerging evidence suggests glaucoma is a neurodegenerative disorder affecting both the eye and brain.
- Glaucoma shares neurodegenerative pathways with Alzheimer's disease (AD) and other tauopathies like CTE and frontotemporal dementia.
Purpose of the Study:
- To review literature from the past 20 years on the pathogenic overlap between primary open angle glaucoma (POAG) and Alzheimer's disease (AD).
- To highlight shared neurodegenerative pathways, including the focal adhesion and tau spreading hypotheses.
Main Methods:
- Systematic literature review of PubMed publications over the last 20 years.
- Analysis of studies investigating neurodegenerative pathways in glaucoma and AD.
- Examination of genetic associations, such as the Apolipoprotein E (APOE) gene.
Main Results:
- The Apolipoprotein E (APOE) gene is associated with both AD and POAG.
- Evidence supports shared neurodegenerative mechanisms between glaucoma and tauopathies.
- Transsynaptic neurodegeneration pathways may be common to AD, tauopathies, and glaucoma.
Conclusions:
- Glaucoma and AD exhibit significant pathogenic overlap.
- Understanding these shared pathways may lead to novel therapeutic strategies for both conditions.
- Further research into neurodegenerative mechanisms is crucial for treating glaucoma and related brain disorders.
Related Concept Videos
Glaucoma: Overview
1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
Photoreceptors and Visual Pathways
8.0K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
8.0K
Open Angle Glaucoma: Treatment
824
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
824
Angle Closure Glaucoma: Treatment
952
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
952
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
95
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
95
Glial Cells
91.6K
Overview
91.6K


